Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,466
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
FRANCIS  AMAYOA ANYAKA
ID: UNCST-2024-R003877
 INTEGRATING ENVIRONMENTAL SUSTAINABILITY INTO RESEARCH ETHICS REVIEW IN UGANDA: PERSPECTIVES OF RESEARCH ETHICS COMMITTEE MEMBERS.
REFNo: HS7784ES

General Objective To assess the awareness, attitudes, and practices of RECs regarding environmental sustainability, and to identify practical strategies for enhancing its integration into research ethics review. Specific Objectives 1. To assess awareness among REC members regarding environmental sustainability in research. 2. To examine the attitudes and perceptions of REC members toward incorporating environmental sustainability into ethics review processes. 3. To assess current practices for integration of environmental considerations into REC ethics review processes. 4. To identify the barriers and facilitators that influence the integration of environmental sustainability into research ethics review by RECs. 5. To propose strategies for strengthening ethical oversight systems to effectively incorporate environmental sustainability into research governance.
Uganda 2026-05-28 15:58:40 2029-05-28 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Alex Saturday
ID: UNCST-2023-R007459
 Effect of Land Use on Water Quality and Biotic Assemblages of Lake Nyabihoko, Western Uganda
REFNo: NS1120ES

i) To assess LULC change patterns from 1992 to 2022 (i.e., 1992, 2002, 2012, and 2022) in the Lake Nyabihoko sub-catchment.
ii) To investigate the spatial and seasonal variability in the physicochemical (i.e., turbidity, temp, DO, EC, pH, TDS, TP, TN, NH4-N, and NO3-N) parameters of water in Lake Nyabihoko.
iii) To investigate spatial and seasonal variability in macroinvertebrate composition, abundance, and diversity in the study area
iv) To investigate phytoplankton composition, abundance, diversity and biomass between wet and dry seasons and among the study stations.

 Uganda 2026-05-28 15:48:35 2029-05-28 Natural Sciences Non-Clinical Trial Degree Award
Dan Ngabirano
ID: UNCST-2025-R021195
 Beyond Legal and other Formal Approaches to the Grand Corruption Problem in Uganda: The Role of Indigenous African Customary Laws, Norms and Institutions
REFNo: SS4691ES

a) To study and document the strength and limitations of relying on legal and other formal approaches to grand corruption in Uganda. b) To interrogate the efficacy of customary laws, norms and institutions in the fight against grand corruption while relying on case studies from Buganda, Bunyoro, Bugisu, Acholi, Kigezi Tswana and Asante societies c)To inquire into the practicability of relying on customary laws, norms and institutions in the fight against corruption in Uganda and whether these should exist as alternatives or rather compliment current legal and formal approaches.
Uganda 2026-05-28 15:46:29 2029-05-28 Social Science and Humanities Non-Clinical Trial Degree Award
Opar BernardToliva
ID: UNCST-2026-R023349
 ASSESSING THE BURDEN AND RESEARCH CAPACITY ON SNAKEBITE ENVENOMING IN NORTHERN UGANDA
REFNo: HS7038ES

To assess the hospital incidence, clinical management practices, and research capacity for snakebite envenoming in Uganda, with the aim of identifying potential clinical trial sites for an upcoming antivenom clinical trial.
 Uganda 2026-05-28 15:42:48 2029-05-28 Medical and Health Sciences Non-Clinical Trial Non-degree Award
JOSHUA KIPTOO
ID: UNCST-2025-R021984
 Use of Physiologically Based Pharmacokinetic (PBPK) Modelling Approach to Predict Infant Exposure to Bedaquiline, Lamivudine, and Lumefantrine Via Breastmilk
REFNo: HS7748ES

General Objective: To determine infant plasma exposure to Lamivudine, Lumefantrine, and Bedaquiline via breast milk change over the first year of life (0-12 months) Specific objectives 1. To develop a PBPK model for the prediction of infant plasma exposure to Bedaquiline, Lamivudine, and Lumefantrine via breast milk 2. To determine the variability in infant plasma exposure to Bedaquiline, Lamivudine, and Lumefantrine via breast milk during the first year of life (0-12 months)
Uganda 2026-05-28 15:39:46 2029-05-28 Medical and Health Sciences Non-Clinical Trial Degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS